期刊文献+
共找到5篇文章
< 1 >
每页显示 20 50 100
Peroxisome proliferator activated receptor-γ and the ubiquitin-proteasome system in colorectal cancer 被引量:3
1
作者 Ioannis A Voutsadakis 《World Journal of Gastrointestinal Oncology》 SCIE CAS 2010年第5期235-241,共7页
Peroxisome proliferator activated receptor-γ (PPARγ), a transcription factor of the nuclear receptor superfamily plays a significant role in colorectal cancer pathogenesis. In most experimental systems PPARγ activa... Peroxisome proliferator activated receptor-γ (PPARγ), a transcription factor of the nuclear receptor superfamily plays a significant role in colorectal cancer pathogenesis. In most experimental systems PPARγ activation has tumor suppressing effects in the colon. PPARγ is regulated at multiple levels by the ubiquitin-proteasome system (UPS). At a first level, UPS regulates PPARγ transcription. This regulation involves both PPARγ transcription specific factors and the general transcription machinery. At a second level UPS regulates PPARγ and its co-factors themselves, as PPARγ and many co-factors are proteasome substrates. At a third level of regulation, transduction pathways working in parallel but also having interrelations with PPARγ are regulated by the UPS, creating a network of regulation in the colorectal carcinogenesisrelated pathways that are under UPS control. Activation of PPARγ transcription by direct pharmacologic activators and by stabilization of its molecule by proteasome inhibitors could be strategies to be exploited in colorectal cancer treatment. 展开更多
关键词 peroxisome proliferator activated receptor-γ UBIQUITIN PROTEASOME COLORECTAL cancer CARCINOGENESIS
下载PDF
美洛昔康对急性肺损伤兔肺组织 COX -2与 PPAR -γmRNA 表达的影响 被引量:1
2
作者 翁翠莲 汪建新 瞿跃进 《中国急救医学》 CAS CSCD 北大核心 2014年第12期1119-1122,I0009,共5页
目的:观察美洛昔康对内毒素(endotoxin, ET)复制急性肺损伤(ALI)时兔肺组织环氧合酶-2( cyclooxygenase -2, COX -2)和过氧化物酶增殖体激活受体-γ( peroxisome proliferation activated receptor -γ, PPAR-γ) mRN... 目的:观察美洛昔康对内毒素(endotoxin, ET)复制急性肺损伤(ALI)时兔肺组织环氧合酶-2( cyclooxygenase -2, COX -2)和过氧化物酶增殖体激活受体-γ( peroxisome proliferation activated receptor -γ, PPAR-γ) mRNA变化的影响,来探讨其对ALI保护作用的机制。方法将24只日本大耳白兔随机分为生理盐水对照组( A组)、内毒素致伤组( B组)、美洛昔康干预组(C组)。用ET(700μg/kg)静脉注射复制兔子ALI模型,美洛昔康(2.5 mg/kg)进行干预,观测兔动脉血气、光镜肺组织病理、肺组织中COX-2 mRNA与PPAR-γmRNA的表达。结果 COX-2 mRNA 表达 B 组显著高于 A 组(P <0.01),C 组显著低于 B 组(P<0.01)。PPAR-γmRNA表达B组显著低于A组(P<0.01),C组显著高于B组(P<0.01)。结论美洛昔康可通过下调COX-2 mRNA和上调PPAR-γmRNA的表达,在一定程度上对兔内毒素性ALI产生保护作用。 展开更多
关键词 急性肺损伤(ALI) 环氧合酶-2(COX-2) 过氧化物酶增殖体激活受体-γ(ppar-γ) 美洛昔康 Acute lung injury(ALI) Cyclooxygenase-2(COX-2) peroxisome proliferation activated receptor -γ( ppar-γ)
下载PDF
PPAR -γ激动剂对 LPS 诱导的小鼠 ARDS 肺泡上皮钠通道-γ亚基的调控
3
作者 叶媛 何婧 +2 位作者 戚迪 冯龙华 王导新 《中国急救医学》 CAS CSCD 北大核心 2014年第8期729-733,I0001,共6页
目的:探讨过氧化物酶增殖体活化受体-γ( PPAR-γ)激动剂对LPS诱导的小鼠ARDS的保护作用及其对肺泡上皮细胞钠通道-γ亚基( ENaC-γ)的调控作用。方法40只雄性BALB/C小鼠随机分为对照组( Control组)、模型组( LPS组)、罗格列... 目的:探讨过氧化物酶增殖体活化受体-γ( PPAR-γ)激动剂对LPS诱导的小鼠ARDS的保护作用及其对肺泡上皮细胞钠通道-γ亚基( ENaC-γ)的调控作用。方法40只雄性BALB/C小鼠随机分为对照组( Control组)、模型组( LPS组)、罗格列酮治疗组( RGZ组,LPS+罗格列酮)及GW9662干预组( GW9662组,LPS+GW9662+罗格列酮),每组10只。处理后收集相关标本,ELISA测定肺泡灌洗液( BALF)中IL-1β和TNF-α水平。肺组织湿/干比( W/D)测定肺水肿程度。 HE染色观察肺组织病理变化并进行肺组织损伤评分。用免疫组织化学法和Western blot测定肺组织ENaC-γ蛋白的表达。 RT-PCR测定ENaC-γmRNA的表达。结果与Control组比较,LPS组、RGZ组和GW9662组中IL-1β和TNF-α水平、W/D值、HE染色肺组织损伤程度及评分明显升高( P<0.05);与LPS组比较,RGZ组各指标水平及肺损伤评分明显下降(P<0.05),但LPS组和GW9662组比较差异无统计学意义(P>0.05)。 LPS造模后,LPS组(210±15IOD,0.18±0.02,0.22±0.04)、RGZ组(450±30IOD,0.43±0.03,0.45±0.03)、GW9662组(235±35IOD,0.21±0.03,0.25±0.02)肺组织ENaC-γ蛋白和mRNA的表达明显低于Control组(600±25IOD,0.64±0.01,0.67±0.02,P<0.05),RGZ组与LPS组和GW9662比较差异有统计学意义(P<0.05),但LPS组和GW9662组比较差异无统计学意义(P>0.05)。结论 PPAR-γ受体激动剂可能从转录水平上调肺泡ENaC-γ的表达,从而减轻LPS诱导的小鼠ARDS肺水肿程度,发挥保护性作用。 展开更多
关键词 过氧化物酶增殖体活化受体-γ(ppar-γ) 罗格列酮 急性呼吸窘迫综合征(ARDS) 上皮细胞钠通道(ENaC) peroxisome proliferator activated receptor -γ(ppar-γ) Acute respiratory distress syndrome (ARDS) Epithelial sodium channel (ENaC)
下载PDF
Osteoporosis and obesity: Role of Wnt pathway in human and murine models 被引量:20
4
作者 Graziana Colaianni Giacomina Brunetti +2 位作者 Maria Felicia Faienza Silvia Colucci Maria Grano 《World Journal of Orthopedics》 2014年第3期242-246,共5页
Studies concerning the pathophysiological connection between obesity and osteoporosis are currently an intriguing area of research.Although the onset of these two diseases can occur in a different way,recent studies h... Studies concerning the pathophysiological connection between obesity and osteoporosis are currently an intriguing area of research.Although the onset of these two diseases can occur in a different way,recent studies have shown that obesity and osteoporosis share common genetic and environmental factors.Despite being a risk factor for health,obesity has traditionally been considered positive to bone because of beneficial effect of mechanical loading,exerted by high body mass,on bone formation.However,contrasting studies have not achieved a clear consensus,suggesting instead that excessive fat mass derived from obesity condition may not protect against osteoporosis or,even worse,could be rather detrimental to bone.On the other hand,it is hitherto better established that,since adipocytes and osteoblasts are derived from a common mesenchymal stem cell precursor,molecules that lead to osteoblastogenesis inhibit adipogenesis and vice versa.Here we will discuss the role of the key molecules regulating adipocytes and osteoblasts differentiation,which are peroxisome proliferators activated receptor-γand Wnts,respectively.In particular,wewill focus on the role of both canonical and non-canonical Wnt signalling,involved in mesenchymal cell fate regulation.Moreover,at present there are no experimental data that relate any influence of the Wnt inhibitor Sclerostin to adipogenesis,although it is well known its role on bone metabolism.In addition,the most common pathological condition in which there is a simultaneous increase of adiposity and decrease of bone mass is menopause.Given that postmenopausal women have high Sclerostin level inversely associated with circulating estradiol level and since the sex hormone replacement therapy has proved to be effective in attenuating bone loss and reversing menopause-related obesity,we hypothesize that Sclerostin contribution in adipogenesis could be an active focus of research in the coming years. 展开更多
关键词 OSTEOPOROSIS OBESITY Bone FAT Wnt peroxisome proliferators activated receptor-γ DICKKOPF SCLEROSTIN
下载PDF
Protective Effect of Telmisartan on Endothelial Cells Exposed to High Glucose Levels in vitro
5
作者 黄俊 肖静 +2 位作者 赫连蔓 鲁爱粉 吴均芳 《South China Journal of Cardiology》 CAS 2009年第4期222-226,共5页
Objectives To investigate the effect of telmisartan on human umbilical vein endothelial cells (HUVEC) exposed to high glucose in vitro and the related mechanism. Methods HUVECs were incubated with telmisartan and gl... Objectives To investigate the effect of telmisartan on human umbilical vein endothelial cells (HUVEC) exposed to high glucose in vitro and the related mechanism. Methods HUVECs were incubated with telmisartan and glucose (5 mmol/L, 30 mmot/L) at 0 h, 12 h, 24 h, 36 h, 48 h, respectively. The level of malondialdehyde (MDA) and superoxide dismutase (SOD) in the supernatant of cultured endothelial cells was measured by thiobarbituric acid test and xanthine oxidase test. The expression of PPAR-γ was determined at 24 hour with Western blot technique. Results When the endothelial cells were cultured in high glucose environment, the MDA level was significantly increased, but the SOD activity and the protein expression of PPAR-γ were markedly decreased. However, the high glucose-induced effects were inhibited by telmisartan intervention. Conclusion Telmisartan can decrease oxidative stress and increase PPAR-γ expression of endothelial cells in high glucose environment. (S Chin J Cardio12009 ; 10 (4) : 222 -226) 展开更多
关键词 human umbilical vein endothelial cell (HUVEC) TELMISARTAN Malondialdehyde (MDA) superoxide dismutase (SOD) peroxisome proliferator activated receptors γ ppar-γ)
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部